NYMOX PHARMACEUTICAL CORPORATION Cash Flows From Used In Financing Activities
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Cash Flows From Used In Financing Activities of $2.60 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-06-03.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2025-06-03
- NYMOX PHARMACEUTICAL CORPORATION cash flows from used in financing activities for the quarter ending 2024-12-31 was $750.00K, a 15.82% decline year-over-year.
- NYMOX PHARMACEUTICAL CORPORATION cash flows from used in financing activities for the quarter ending 2023-12-31 was $891.00K.
- NYMOX PHARMACEUTICAL CORPORATION cash flows from used in financing activities for the quarter ending 2023-09-30 was $1.21M.
- NYMOX PHARMACEUTICAL CORPORATION cash flows from used in financing activities for the quarter ending 2023-06-30 was $690.00K, a 62.52% decline year-over-year.
| Period end | Cash Flows From Used In Financing Activities 3 month | Cash Flows From Used In Financing Activities 3 month as first filed | Cash Flows From Used In Financing Activities 6 month | Cash Flows From Used In Financing Activities 9 month | Cash Flows From Used In Financing Activities 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $750.00K derived: 20-F 12 month − 6-K 9 month · filed 2025-06-03 | $2.60M 20-F · filed 2025-06-03 | |||
| 2024-09-30 | $1.85M 6-K · filed 2025-01-02 | ||||
| 2023-12-31 | $891.00K derived: 20-F 12 month − 6-K 9 month · filed 2025-06-03 | $2.10M derived: sum of 2 quarters · filed 2025-06-03 | $2.79M derived: sum of 3 quarters · filed 2025-06-03 | $2.73M 20-F · filed 2025-06-03 | |
| 2023-09-30 | $1.21M derived: 6-K 9 month − 6-K 6 month · filed 2025-01-02 | $1.90M derived: sum of 2 quarters · filed 2025-01-02 | $1.84M 6-K · filed 2025-01-02 | $1.78M derived: sum of 4 quarters · filed 2025-06-03 | |
| 2023-06-30 | $690.00K derived: 6-K 6 month − 6-K 3 month · filed 2023-08-14 | $629.00K 6-K · filed 2023-08-14 | $577.00K derived: sum of 3 quarters · filed 2025-06-03 | $517.00K derived: sum of 4 quarters · filed 2025-06-03 | |
| 2023-03-31 | -$61.00K 6-K · filed 2023-05-12 | -$113.00K derived: sum of 2 quarters · filed 2025-06-03 | -$173.00K derived: sum of 3 quarters · filed 2025-06-03 | $1.67M derived: sum of 4 quarters · filed 2025-06-03 | |
| 2022-12-31 | -$52.00K derived: 20-F 12 month − 6-K 9 month · filed 2025-06-03 | -$112.00K derived: sum of 2 quarters · filed 2025-06-03 | $1.73M derived: sum of 3 quarters · filed 2025-06-03 | $5.78M 20-F · filed 2025-06-03 | |
| 2022-09-30 | -$60.00K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-15 | $1.78M derived: sum of 2 quarters · filed 2023-11-15 | $5.83M 6-K · filed 2023-11-15 | $5.77M derived: sum of 4 quarters · filed 2024-08-29 | |
| 2022-06-30 | $1.84M derived: 6-K 6 month − 6-K 3 month · filed 2023-08-14 | $5.89M 6-K · filed 2023-08-14 | $5.83M derived: sum of 3 quarters · filed 2024-08-29 | $5.77M derived: sum of 4 quarters · filed 2024-08-29 | |
| 2022-03-31 | $4.05M 6-K · filed 2023-05-12 | -$4.05M 6-K · filed 2022-05-13 | $3.99M derived: sum of 2 quarters · filed 2024-08-29 | $3.93M derived: sum of 3 quarters · filed 2024-08-29 | $11.15M derived: sum of 4 quarters · filed 2024-08-29 |
| 2021-12-31 | -$59.00K derived: 20-F 12 month − 6-K/A 9 month · filed 2024-08-29 | -$118.00K derived: sum of 2 quarters · filed 2024-08-29 | $7.11M derived: sum of 3 quarters · filed 2024-08-29 | $7.04M 20-F · filed 2024-08-29 | |
| 2021-09-30 | -$59.00K derived: 6-K/A 9 month − 6-K 6 month · filed 2022-11-16 | $7.16M derived: sum of 2 quarters · filed 2022-11-16 | $7.10M 6-K/A · filed 2022-11-16 | $7.05M derived: sum of 4 quarters · filed 2023-05-02 | |
| 2021-06-30 | $7.22M derived: 6-K 6 month − 6-K 3 month · filed 2022-08-15 | $7.16M 6-K · filed 2022-08-15 | $7.11M derived: sum of 3 quarters · filed 2023-05-02 | $15.72M derived: sum of 4 quarters · filed 2023-05-02 | |
| 2021-03-31 | -$60.00K 6-K · filed 2022-05-13 | -$118.00K derived: sum of 2 quarters · filed 2023-05-02 | $8.50M derived: sum of 3 quarters · filed 2023-05-02 | $8.43M derived: sum of 4 quarters · filed 2023-05-02 | |
| 2020-12-31 | -$58.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-05-02 | $8.56M derived: sum of 2 quarters · filed 2023-05-02 | $8.49M derived: sum of 3 quarters · filed 2023-05-02 | $8.42M 20-F · filed 2023-05-02 | |
| 2020-09-30 | $8.62M derived: 6-K 9 month − 6-K 6 month · filed 2021-11-12 | $8.55M derived: sum of 2 quarters · filed 2021-11-12 | $8.48M 6-K · filed 2021-11-12 | $8.39M derived: sum of 4 quarters · filed 2022-03-30 | |
| 2020-06-30 | -$71.00K derived: 6-K 6 month − 6-K 3 month · filed 2021-08-13 | -$139.00K 6-K · filed 2021-08-13 | -$228.00K derived: sum of 3 quarters · filed 2022-03-30 | -$291.00K derived: sum of 4 quarters · filed 2022-03-30 | |
| 2020-03-31 | -$68.00K 6-K · filed 2021-05-14 | -$157.00K derived: sum of 2 quarters · filed 2022-03-30 | -$220.00K derived: sum of 3 quarters · filed 2022-03-30 | -$285.00K derived: sum of 4 quarters · filed 2022-03-30 | |
| 2019-12-31 | -$89.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-03-30 | -$152.00K derived: sum of 2 quarters · filed 2022-03-30 | -$217.00K derived: sum of 3 quarters · filed 2022-03-30 | $4.72M 20-F · filed 2022-03-30 | |
| 2019-09-30 | -$63.00K derived: 6-K 9 month − 6-K 6 month · filed 2020-11-13 | -$128.00K derived: sum of 2 quarters · filed 2020-11-13 | $4.81M 6-K · filed 2020-11-13 | $9.81M derived: sum of 4 quarters · filed 2021-03-29 | |
| 2019-06-30 | -$65.00K derived: 6-K 6 month − 6-K 3 month · filed 2020-08-14 | $4.88M 6-K · filed 2020-08-14 | $9.88M derived: sum of 3 quarters · filed 2021-03-29 | $11.88M derived: sum of 4 quarters · filed 2021-03-29 | |
| 2019-03-31 | $4.94M 6-K · filed 2020-05-14 | $9.94M derived: sum of 2 quarters · filed 2021-03-29 | $11.94M derived: sum of 3 quarters · filed 2021-03-29 | $18.04M derived: sum of 4 quarters · filed 2021-03-29 | |
| 2018-12-31 | $5.00M derived: 20-F 12 month − 6-K 9 month · filed 2021-03-29 | $7.00M derived: sum of 2 quarters · filed 2021-03-29 | $13.10M derived: sum of 3 quarters · filed 2021-03-29 | $14.93M 20-F · filed 2021-03-29 | |
| 2018-09-30 | $2.00M derived: 6-K 9 month − 6-K 6 month · filed 2019-11-13 | $8.10M derived: sum of 2 quarters · filed 2019-11-13 | $9.93M 6-K · filed 2019-11-13 | $10.31M derived: sum of 4 quarters · filed 2020-03-30 | |
| 2018-06-30 | $6.10M derived: 6-K 6 month − 6-K 3 month · filed 2019-08-14 | $7.93M 6-K · filed 2019-08-14 | $8.31M derived: sum of 3 quarters · filed 2020-03-30 | $11.21M derived: sum of 4 quarters · filed 2020-03-30 | |
| 2018-03-31 | $1.83M 6-K · filed 2019-05-15 | $2.21M derived: sum of 2 quarters · filed 2020-03-30 | $5.12M derived: sum of 3 quarters · filed 2020-03-30 | $6.52M derived: sum of 4 quarters · filed 2020-03-30 | |
| 2017-12-31 | $381.00K derived: 20-F 12 month − 6-K 9 month · filed 2020-03-30 | $3.28M derived: sum of 2 quarters · filed 2020-03-30 | $4.68M derived: sum of 3 quarters · filed 2020-03-30 | $5.04M 20-F · filed 2020-03-30 | |
| 2017-09-30 | $2.90M derived: 6-K 9 month − 6-K 6 month · filed 2018-11-13 | $4.30M derived: sum of 2 quarters · filed 2018-11-13 | $4.66M 6-K · filed 2018-11-13 | ||
| 2017-06-30 | $1.40M derived: 6-K 6 month − 6-K 3 month · filed 2018-08-13 | $1.76M 6-K · filed 2018-08-13 | |||
| 2017-03-31 | $354.00K 6-K · filed 2018-05-15 | ||||
| 2016-12-31 | $6.15M 20-F · filed 2019-03-29 | ||||
| 2015-12-31 | $3.50M 20-F · filed 2018-03-30 |